 ROCKVILLE, Md., April 27, 2021 PRNewswire -- REGENXBIO Inc. Nasdaq: RGNX today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapys 24th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. 